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The present study was undertaken to explore the interaction of ciprofloxacin and chloramphenicol with bacterial membranes in
a sensitive and in a resistant strains of Staphylococcus aureus by using 1-anilino-8-naphthalene sulfonate (ANS). The binding of
this probe to the cell membrane depends on the surface potential, which modulates the binding constant to the membrane. We
observed that these antibiotics interacted with the bilayer, thus affecting the electrostatic surface potential. Alterations caused by
antibiotics on the surface of the bacteria were accompanied by a reduction in the number of binding sites and an increase in the
ANS dissociation constant in the sensitive strain, whereas in the ciprofloxacin-resistant strain no significant changes were detected.
The changes seen in the electrostatic surface potential generated in themembrane of S. aureus by the antibiotics provide new aspects
concerning their action on the bacterial cell.
1. Introduction
The plasmatic membrane is a chemoosmotic barrier that
provides an interface between the organism and the envi-
ronment. This bilayer presents an electrochemical potential
(negative in the interior) which plays a basic role in the con-
trol of the exchange of solutes. Disturbances in themembrane
potential can provide a rapid and sensitive indication of those
stimuli that lead to physiological functionally important
changes with respect to bacterial viability [1].
Fluorescent molecules have been extensively used as
probes of biological membranes. These hydrophobic and
amphiphilic probes are associated with membranes when
added to cells or artificial systems, and their resultant fluo-
rescence properties can be used to monitor a variety of mem-
brane characteristics. In general, the addition of effectors
results in the deenergization of cells, which leads to increased
fluorescence from the probes present in the cell suspension,
such as negatively charged 8-anilino-1-naphthalenesulfonate
(ANS) [2].
ANS binding and fluorescence strongly respond to mod-
ulation of the surface potential, with the energy-dependent
quenching being largely due to the generation of ΔΨ and
being accounted for by the movement of the anion across
the membrane and from intramembrane sites in response to
membrane potential [3].
It has been demonstrated that the determination of the
membrane potential based on fluorochromes provides a
useful and sensitive approximation for the monitoring of
the cellular stresses in bacteria [4–6], since both oxidative
and nitrosative stress are able to depolarize the plasmatic
membrane [7].
The effect of the oxidative stress generated by reactive
oxygen species (ROS) has been described as one of the most
important sources of metabolic disturbance and the cellular
damage. These agents are involved in the first important
changes in the plasmatic membrane, and consequently at the
beginning of cellular death [8–10].
Bacterial gyrase inhibitors, including synthetic quinolone
antibiotics, induce a breakdown in iron regulatory dynamics,
which promotes the formation of the ROS that contribute to
cell death [11].
Bactericidal antibiotic killing mechanisms are currently
attributed to the class of specific drug-target interactions.
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However, the understanding of many of the bacterial
responses that occur as a consequence of the primary drug-
target interaction remains incomplete. It is known that
oxidative stress in bacteria can be caused by exogenous agents
that originate toxic effects, and our previous studies have
shown that ciprofloxacin (CIP) and chloramphenicol (CMP),
among others, can stimulate the induction of ROS in different
bacterial species [12–16].
The aim of the present study was to explore the effects
of clinically used antibiotics such as CIP and CMP on the
lipid surface and to estimate the variation in the membrane
potential in Staphylococcus aureus strains.
2. Materials and Methods
2.1. Susceptibility Determination. The antimicrobial activities
of CIP and CMP were evaluated in two strains, one standard
strain S. aureusATCC29213 and other clinical strain S. aureus
by using the standard tube dilution method following the
indications of the Clinical and Laboratory Standards Institute
[17]. The strains were maintained by culture in trypticase soy
broth (TSB) for 24 h at 37∘C, and the minimum inhibitory
concentration (MIC) was determined by using the standard
tube dilution method. Cultures of 24 h in Mueller-Hinton
medium were diluted to 106 CFU/mL, incubated for 10min
at 37∘C, and then the antibiotics were added at different
concentrations (0.125 𝜇g/mL–512𝜇g/mL). Bacterial growth
was observed at 24 h of incubation. MIC was determined
as the lowest antibiotic concentrations at which growth was
completely inhibited after overnight incubation of the tubes
at 37∘C. MICs were determined three times and the median
values are taken.
2.2. ANS Binding Studies. Overnight cultures of S. aureus
ATCC 29213 and clinical strain S. aureus were prepared in
trypticase soy broth. Suspensions were centrifuged, and the
pellets were resuspended in saline phosphate buffer (PBS) pH
7.4 at an optical density of 0.4 at 600 nm.Then, 50𝜇L of these
suspensions was incubated with 256𝜇g/mL of CIP, 4𝜇g/mL
of CMP, or without antibiotic (control) in a total volume of
1mL in PBS.
The suspensions were centrifuged, and 1mL of Triton 1%
V/V in NaCl 10%was added to the pellet.Then, 20 𝜇L of ANS
60𝜇M was added to 50 𝜇L of bacterial suspensions and PBS
to a total volume of 3mL. The assay mixture for the standard
curve consisted of 1mL of bacterial suspensions and different
concentrations of ANS, ranging from 0 to 120𝜇M.The struc-
tural changes on the membrane potential were studied by
using L-anilino naphthalene-8-sulphonate as the fluorescent
probe by the method of Verma et al. [18] and Robertson and
Rottenberg [19]. The fluorescence emission was recorded on
a Spectrofluorometer PTI (Photon Technology International)
Model QuantaMaster 2QM2, with phosphorescence lifetime
measurements taken at excitation and emission wavelengths
of 360 nm and 516 nm, respectively. These experiments were
performed at room temperature (23∘C).
2.3. Measurement of 𝐾
𝑑
and 𝑛 from ANS by Fluorescence
Emission in Bacteria. The approach used to determine the
dissociation constant (𝐾
𝑑
) and the number of binding sites
(𝑛) from the fluorescence yield was as previously reported
by Verma et al. [18] and Robertson and Rottenberg [19]. The
fluorescence developed is recorded, and the data is plotted
as the reciprocal of the fluorescence signal (arbitrary units)
versus the reciprocal of the concentration of ANS. This
produces a straight linewhose extrapolationwith the ordinate
gives the reciprocal of the limiting fluorescence of ANS
(𝐹max). The number of binding sites for ANS was calculated
by plotting the bound ANS per mg protein/free ANS versus
bound ANS per mg protein.
2.4. Statistical Analysis. The assays were carried out at least in
triplicate. Data were expressed as mean ± SD and analyzed by
the Student’s t-test.𝑃 < 0.05was used as the level of statistical
significance.
3. Results and Discussion
S. aureus ATCC 29213 exhibited sensitivity to CIP and CMP,
with MICs of 0.5𝜇g/mL for CIP and 1𝜇g/mL for CMP. In
addition, the clinical strain S. aureus MICs obtained were
32 𝜇g/mL for CIP and 8𝜇g/mL for CMP; according to these
results, the strain was resistant to CIP but sensitive to CMP.
The fluorescence emission of ANS at 516 nm in the presence
of 256𝜇g/mL of CIP, 4𝜇g/mL of CMP or in the absence of
antibiotic was determined with S. aureus ATCC 29213 and
clinical strain S. aureus.
Data were plotted as the reciprocal of the fluorescence
signal (1/F) versus the reciprocal of the concentration of free
ANS (1/ANS), as the reciprocal of the intercept gives the limit
of the ANS fluorescence (𝐹max), a parameter related to the
maximum concentration of bound ANS. From the slope, the
𝐾
𝑑
was obtained from which the affinity of the fluorescent
probe for binding sites on the bilayer could be inferred.
The values of bound ANS and free ANS were calculated
from (1), where
ANS bound (nmol) =
1/𝐹max
1/𝐹
× 100,
ANSfree (nmol) = ANStotal − ANSbound .
(1)
The surface potential (Ψ) was calculated according to (2):
Ψ = 59 log (𝐹/𝐹
𝑜
) , (2)
where 𝐹 corresponds to the fluorescence in the presence
of each antibiotic and 𝐹
𝑜
corresponds to the fluorescence
obtained when Ψ = 0.
The change in membrane potential (ΔΨ) in the presence
of antibiotic with respect to the control without antibiotic was
obtained from the difference between Ψ with and without
antibiotic (3):
ΔΨ = Ψ − Ψcontrol . (3)
The number of binding sites for ANS was calculated by
using (4), in which the intercept represents the value of the
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Table 1: Parameters obtained from the ANS binding studies in
𝑆. 𝑎𝑢𝑟𝑒𝑢𝑠 ATCC 29213 and clinical strain S. aureus.
𝐹max 𝐾𝑑 n Ψ (mV) ΔΨ (mV)
S. aureus ATCC 29213 sensitive to CIP and CMP
Control without antibiotic 143 251 603028 −306 —
Ciprofloxacin 256 𝜇g/mL 70 927 52983 −406 −100
Chloramphenicol 4𝜇g/mL 62 846 48332 −331 −25
Clinical strain S. aureus resistant to CIP
Control without antibiotic 77 902 45110 −287 —
Ciprofloxacin 256 𝜇g/mL 77 937 46865 −302 −15
𝐹max is the fluorescence intensity (related to the maximum concentration of
boundANS), n is the number of binding sites of ANS to themembrane,𝐾
𝑑
is
the dissociation constant, Ψ is the potential at the surface of the membrane
and ΔΨ is the change in surface potential of the membrane in the control
without antibiotic.
reciprocal of 𝑞 (a constant of proportionality), with the value
of 𝑛 being obtained from the slope (𝐾
𝑑
/𝑞𝑛):
ANSfree
𝐹
=
𝐾
𝑑
𝑞𝑛
×
1
[bacteria]
+
1
𝑞
. (4)
The same procedure was performed to determine the
number of binding sites for ANS when the bacterial sus-
pensions were incubated with the antibiotics studied, where
a decrease in the number of binding sites for ANS with
antibiotic would suggest changes in the cell surface.
Any alteration in the binding of ANS to the membrane
of S. aureus in the presence of antibiotics was tested by a
decrease in the number of binding sites for ANS compared
with control. When ANS bounds to phospholipids, the
fluorescence intensity increased with high concentrations
of ANS. However, in the presence of CMP or CIP, the
ANS fluorescence decreased, with this behavior reflecting
competition between CMP and the ANS binding site that
might have been located at the interface of the membrane.
By comparing the values of𝐾
𝑑
, we were able to infer that the
affinity of the probe sites of the bilayer was affected by the two
antibiotics. Moreover, differences in the values of the electric
potentials indicated alterations in the bacterial membranes.
The fluorescence of ANS emission was determined at
516 nm in the presence of CIP and CMP and in the absence
of antibiotic. The data were plotted as the reciprocal of
the fluorescence signal (1/𝐹) versus the reciprocal of the
concentration of ANS (1/ANS) (Figure 1). There was a linear
relationship between fluorescence and the inverse of the
concentration of bound ANS, revealing a change in the
affinity of the membrane in the presence of antibiotic with
respect to control.
Table 1 shows the parameters obtainedwithCMPandCIP
for the surface potential in the absence or presence of the
antibiotics in the S. aureus ATCC 29213 and clinical strain S.
aureus.
Whereas the value of 𝐹max was reduced twofold and the
number of binding sites decreased elevenfold, the 𝐾
𝑑
value
was increased fourfold, compared to the control without
antibiotic in S. aureus ATCC 29213 (sensitive to CIP). In
clinical strain S. aureus (resistant to CIP) there were no
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Figure 1: Scatchard plots of ANS interaction with S. aureus ATCC
29213 control (- - -), treated with ciprofloxacin (—) and treated with
CMP (-⋅⋅-).
significant changes in 𝐹max, number of binding sites, or the
𝐾
𝑑
value. The baseline value of Ψ in the sensitive strain
was −306mV, while in the resistant strain this was −287mV.
The ΔΨ was almost seventimes higher in the sensitive strain
(100mV) than in the resistant one (15mV). CIP, a bactericidal
antibiotic, reduced this value by 33% in the sensitive strain,
while the reduction in the resistant one was only 5%. Finally,
CMP, a bacteriostatic antibiotic, increased the membrane
potential by about 11% in the sensitive strain.
The membrane potential is an important parameter that
controls various cellular processes. It is a sensitive indicator
of energy status and cell viability, with membrane depo-
larization leading to excessive production of ROS which
is an indication of an advance in cellular dysfunction and
precedes many other signs of cellular injury. A reduction in
the potential also provides information about the feasibility
of transferring an electron “in vivo.” In addition, the catalytic
production of oxidative stress from the redox cycle is a
possible mode of action of antibiotics, because it could
indicate interference with the electron transport chain [20,
21].
The changes in the electric potential obtained in the
present work showed alterations in the bacterial membrane
of S. aureus in the presence of CMP and CIP. Furthermore,
changes caused by antibiotics on the surface of the bacteria
were demonstrated by a reduction in the number of binding
sites of the fluorescent probe and an increase in the ANS
dissociation constant.
Montero et al. established that CIP interacts with neutral
and charged membranes at the surface level (headgroup
region). They also postulated that this could be part of
the mechanism of entry of the 6-fluoroquinolones through
the cytoplasmic membrane [3]. Ciprofloxacin is a widely
used antimicrobial agent against Gram positive and Gram
negative, but there are conflicting reports about the effect of
CIP on the bacterial membrane [22, 23].
There are previous results on S. aureus, with liposomes of
E. coli showing interaction of ANS with a lipid bilayer and in
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the presence of 6-FQs as a result of a reduction in the max-
imum concentration of the ANS bound to liposomes [24–
27]. However, there are no comparisons reported between
sensitive and resistant strains in the presence of antibiotics.
The present results demonstrated that the strains had a
particular behavior in the presence of each antibiotic, an
effect that was manifested by the differences obtained in the
bacterial membrane potential. Moreover, on comparing the
sensitive strain with the resistant one, a higher alteration in
the membrane potential was observed in sensitive bacterium
that was associated with the effect of the antibiotic [20, 21].
4. Conclusions
In our previous reports, we demonstrated that CIP and
CMP induce oxidative stress in S. aureus strains, with
sensitive clinical strains producing higher ROS levels than
resistant ones [12–15]. The present work shows that these
antibiotics had an impact on the lipid bilayer, leading to
significant membrane potential changes in S. aureus sensitive
to ciprofloxacin. These observations can be added to the
mechanism of action previously described for the antibiotics
investigated, with the changes generated in the lipid bilayers
of S. aureus contributing new aspects about the action of these
antibiotics on the bacterial cell.
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